Pharmacogenomic Testing: Delivering Precision MedicineBy reducing adverse drug responses, improving efficacy, and ensuring each patient gets the drug they are most likely to respond to, pharmacogenomics testing helps deliver the promise of precision medicine. In order to help empower the personalization of cancer treatment, we offer pharmacogenomic testing for doctors, hospitals, and cancer centers, as well as for biopharma and biotech companies engaged in oncology-focused clinical trials.
Below is a sample of the pharmacogenomic genotyping assays we offer for central nervous system (CNS) drugs. In addition to conventional pharmacogenomics tests, we are experienced in providing custom assay development and validation.
Intergenic between GABRR1 and GABRR2